Skip to main content


DC Circuit upholds OPPS reimbursement reductions for 340B drugs

By The National Law Review  
   August 04, 2020

On July 31, 2020, the US Court of Appeals for the District of Columbia Circuit held that the Centers for Medicare and Medicaid Services (CMS) has authority under the Social Security Act to reduce Medicare payment rates for 340B drugs reimbursed under the Medicare Hospital Outpatient Prospective Payment System (OPPS). This decision reverses a prior district court ruling and preserves the payment cuts for the foreseeable future.

Full story

Get the latest on healthcare leadership in your inbox.